Publication:
Effects of Whey protein, Omega-3 fatty acid and Roux-En-Y gastric bypass on body weight, biochemical parameters and organ functions in an obese rat model: experimental research

dc.contributor.coauthorMert-Biberoğlu, Fatma
dc.contributor.coauthorErdem, Nihal Zekiye
dc.contributor.coauthorÖzdenkaya, Yaşar
dc.contributor.coauthorÖzdemir, Ekrem Musa
dc.contributor.kuauthorSaka, Burcu
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.contributor.yokid222921
dc.date.accessioned2024-11-09T23:38:50Z
dc.date.issued2023
dc.description.abstractPurpose: Extreme obesity (EO) is one of the biggest public health problems in the world and has grown considerably over the years. The aim of the study is to examine the effect of Roux-en-Y gastric bypass (RYGB), whey protein (WP), and omega-3 polyunsaturated fatty acid (PUFA) supplementation applied to EO rats on weight loss, histopathological changes in internal organs and biochemical alterations. Materials and Methods: Wistar albino female rats (n = 28) were used in the study and randomly divided into four groups. All rats were made obese by adding high fructose corn syrup (HFCS) to their drinking water. After the EO, WP and omega-3 PUFA supplementation was given and RYGB process was applied. At the end of the study, glucose, total cholesterol, HDL, VLDL, AST, ALT and uric acid changes and liver, kidney and pancreatic tissues were evaluated histopathologically. Results: WP and omega-3 PUFA supplementation decreased body weight (p > 0.05). Omega-3 PUFA and RYGB caused a decrease in total cholesterol (p < 0.05), WP decreased HDL (p < 0.05), WP and omega-3 PUFA caused an increase in ALT (p < 0.05). WP has been shown to have greater curative effects in rat liver and kidney tissues. It has been determined that RYGB causes necrosis in the liver and HFCS causes inflammation in the kidney. Conclusion: In the study; the positive effects of WP, omega-3 PUFA and bariatric surgery on obesity and dyslipidemia have been demonstrated. With this result, it was determined that WP, omega-3 PUFA supplementation and bariatric surgery were not superior to each other. Graphical abstract: [Figure not available: see fulltext.]
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.indexedbyWoS
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.identifier.doi10.1007/s11695-023-06560-z
dc.identifier.issn0960-8923
dc.identifier.linkhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85150949050&doi=10.1007%2fs11695-023-06560-z&partnerID=40&md5=ee9d322364be0bdbadb67ff6278d1872
dc.identifier.scopus2-s2.0-85150949050
dc.identifier.urihttp://dx.doi.org/10.1007/s11695-023-06560-z
dc.identifier.urihttps://hdl.handle.net/20.500.14288/13008
dc.identifier.wos960207000001
dc.keywordsExtreme obesity
dc.keywordsOmega-3 PUFA
dc.keywordsRoux-en-Y gastric bypass
dc.keywordsWhey protein
dc.languageEnglish
dc.publisherSpringer
dc.sourceObesity Surgery
dc.subjectMedicine
dc.titleEffects of Whey protein, Omega-3 fatty acid and Roux-En-Y gastric bypass on body weight, biochemical parameters and organ functions in an obese rat model: experimental research
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authoridN/A
local.contributor.kuauthorSaka, Burcu

Files